US FDA's approval of Boston Scientific Corp.'s Emblem MRI S-ICD subcutaneous implantable defibrillator, announced Aug. 9, is the latest in a string of approvals of ImageReady magnetic resonance imaging-compatible devices that should help the company become more competitive in the cardiac rhythm management market.
Emblem MRI S-ICD, which earned a CE mark in April, is an MR-compatible version of the Emblem S-ICD. (Also see "APPROVALS ANALYSIS: Big Month For Cardio Devices, But Down...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?